Luciferase Assays Market Key Players – Life Technologies, Sigma Aldrich, Thermo Fisher, Promega, Clontech, Invivogen, Roche Applied Sciences

Luciferase Assays Market: Region-wise Outlook

In terms of geography, luciferase assays market has been divided into seven regions including North- America, Eastern Europe, Western Europe, Asia- Pacific excluding Japan, Japan Middle-East & Africa and Latin America. North America is expected to remain the dominating region while Asia Pacific is expected to emerge as a fastest growing region. Strong research funding and government to study newer assay methods makes North America the dominating region. Economically developing regions such as Asia Pacific has many companies focusing their resources in this region and trying to explore the luciferase assay market potential.

A bioluminescence experiment requires a paired set of biochemical: an enzyme named luciferase and a substrate, which is a molecule that emits light upon interacting with the enzyme or photoprotein. For each of the bioluminescent system required there is a unique co- factors and buffers that are required. Around us there are a lot of biological, natural and light producing systems which produces the enzyme named luciferases. The substrate of luciferases is coin as luciferins. Emil Heinrich DuBois-Reymond, a German physiologist coined both these terms. Luciferases and luciferins are both involved in totally different reactions. For instance, the most commonly used luciferase detects the biological energy molecule adenosine triphosphate.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5565

Luciferase Assays Market: Drivers and Restraints

The market for luciferase assay is expected to upsurge owing to its penetrating usage in research to study the gene expression. Moreover, these luciferases has become powerful tool in molecular biology and genetic engineering where they have replaced chloramphenicol acetyltrans-ferase gene as a reporter. Bioluminescence is now filling its own niches as well as competing with chemiluminescence. ATP detection via firefly luciferase, for example, has no chemiluminescent counterpart. There is tremendous technological development in the luciferase assay market where the current luciferase technologies permit the quantitative visualization of gene expression at single-cell resolution by imaging its luminescence in real-time using a highly sensitive charged-coupled device (CCD) camera.

Luciferase Assays Market: Overview

These luciferases are used in bioluminescence assays as researchers believe that where there is light there would be ATP and measuring the light emitted while carrying out the bioluminescence assay is the measure of the metabolic activity. Today luciferases is used in all forms of testing to check the ATP. It is used to check the microbial contamination in many of the beverages company. There are a number of studies going on where the researchers link the interest gene with the luciferases to study the metabolic activity. The investigator through this linkage is able to follow gene expression at different stages of development in a transgenic organism.

Luciferase Assays Market: Key Market Participants

Some of the luciferase assays market participants are Life Technologies, Sigma Aldrich, Thermo Fisher, Promega, Clontech, Invivogen, Roche Applied Sciences, Switchgear Genomics, Origene, Perkin Elmer, EMD Millipore, Clontech, Gold Biotechnology, Lonza and GE Healthcare Life Sciences. New product launch, collaborations and acquisitions are few of the strategies the luciferase assays market players undertake. For instance, Promega Corporation introduced a new product named Nano-Glo Dual-Luciferase Reporter (NanoDLR) Assay, a two-reporter system that incorporates NanoLuc luciferase technology, providing increased data quality and greater sensitivity for biologically complex applications.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5565

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Luciferase Assays Market: Segmentation

On the basis of assay type the luciferase assays market can be segment as:

  • Beta-galactosidase (LacZ) assays
  • Luciferase assays
  • Fluorescent protein related assays
  • Chloramphenicol acetyltransferase (CAT) assays
  • Others

On the basis of application the luciferase assays market can be segment as:

  • Gene expression
  • Post-translational modification
  • Protein-protein interaction
  • Metabolic activity
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/5565

Nanomaterials Market Size, Share | Industry Forecast Report 2025

The science of nanomaterials has created a lot of expectation amongst various end user industries. With the increasing applications of nanomaterials, the demand for it is increasing at an increasing rate and is becoming a part of daily lives. Nanomaterials are important product under the nanotechnology. They embrace nanoparticles, smaller than 100 nanometres in at least one dimension. Nanomaterials are widely used in healthcare, electronics, cosmetics and other areas nowadays. Continuous improvement and innovation in the field is driving the growth of the global nanomaterials market.

The extraordinary physical and chemicals properties of materials at the nanometre scale enable novel applications ranging from energy conservation and structural strength enhancement to antimicrobial properties and self-cleaning surfaces.  The nanotechnology is being increasingly modernised by expending largely on R&D activities which is resulting in the advancement of existing technologies and innovations with reference to the new materials.

Energy storage and construction market is providing a huge growth potential to these materials and driving the overall market for nanomaterials. The increasing electronics market is also providing opportunities to the global nanomaterials market due to the falling prices and improving materials property and efficiency.

Get a Sample Copy of Report:  https://www.futuremarketinsights.com/reports/sample/rep-gb-696

Nanomaterials Market: Drivers & Restraints

The market penetration of the already existing materials and ongoing development of new materials and applications is driving the global nanomaterials market. The unabated market for nanomaterials is being strongly supported by the governmental funding to support the potential growth. The increasing availability of several methods in the field of nanotechnology and new novel methods for fabricating the patterned nanostructures is offering opportunity for better modeling. Some of the other drivers for the growth of global nanomaterials market is partnerships & strategic alliances, increasing number of market players and newer material developments. One of the major factor restraining the growth of global nanomaterials market implies to the growing concerns over environmental impact and toxicity of nanomaterials.

 

Nanomaterials Market: Region-wise Outlook

The global nanomaterials market is expected to register a favourable growth for the forecast period, 2015?2025. North America and Europe are the two prominent regions that are projected to endure the control on the global nanomaterials market. Decreasing prices due to the increasing mass production is responsible for the robust growth of the above mentioned markets. The demand for nanomaterials is also surging across Asian regions. The Asia-Pacific region is projected to witness remarkable growth rate owning to the greater demand of nanomaterials in the developing regions like India and China and their continuous research and developmental activities.

Nanomaterials: Key Players

There are a lot of players in the nanomaterials industry of which some of the key market participants in global nanomaterials market are BASF, EMFUTUR Technologies, Evonik Industries, Sigma-Aldrich Co. LLC, Bayer AG, SkySpring Nanomaterials, Altair Nanotechnologies Inc., and Nanomaterials Company and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Request Report Methodology:  https://www.futuremarketinsights.com/askus/rep-gb-696

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-696

 

Nanomaterials Market: Segmentation

On the basis of material type, the global nanomaterials market is segmented as follows:

  • Metal Oxide (Silica, Aluminium Oxide/Hydroxide, Titanium Dioxide, Zinc Oxide, Iron Oxide, Other Metal Oxides)
  • Metals
  • Chemicals and Polymers (Nanopharmaceuticals, Liposomes, Other Chemicals & Polymers)
  • Nanotubes
  • Others (Conventional Materials and New Materials)

On the basis of applications the global nanomaterials market is segmented as follows:

  • Construction
  • Packaging
  • Consumer Goods
  • Electrical and Electronics
  • Energy
  • Health Care
  • Transportation
  • Others

Non-Invasive Blood Glucose Monitoring Devices Market Size, Segmentation, Sales Channels, Type, Demand and Future Opportunities and Forecast 2022 – 2027

Diabetes has evolved as one of the primary healthcare epidemic characterized by high sugar levels and principle cause of mortality worldwide. In 2014, World Health Organization (WHO) estimated 8.5% of adults living with diabetes. A diabetic person cannot either synthesize enough insulin (type 1 diabetes) or either does not make enough insulin or cannot effectively use the insulin produced by the body (type 2 diabetes). Another type of diabetes that occur in women during her pregnancy is gestational diabetes. However, gestational diabetes is usually resolved after delivery but can precede towards type 2 diabetes later in a women’s life. Most of the continuous glucose monitoring devices are invasive and involves use of needles leading to increased chance of infection. Furthermore, the invasive glucose monitoring device is considered to be discrete glucose measurement system which cannot be practically used for continuous monitoring of blood glucose. Certain evidences of hyperglycemia between measurements are however not recorded thus resulting in false or no representation of the blood glucose pattern. Noninvasive monitoring of glucose levels eliminates the need of painful pricking with increased risk of infection, and amount of damage caused to the finger tissue.

Request Sample Copy of Report: @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2613
Therefore, non-invasive continuous glucose monitoring devices are being widely investigated and studied over the past few years for their ability to monitor glucose continuously under highly controlled (e.g. in-clinic) conditions. Various techniques that involves measurement of blood glucose levels non-invasively includes, Near Infrared Spectroscopy (NIRS), Mid -Infrared Spectroscopy (Mid-IRS), Raman Spectroscopy, Photo-acoustic Spectroscopy (PA), Optical Coherence Tomography (OCT) and many more.
Non- Invasive Blood Glucose Monitoring Devices Market: Overview 

Rising prevalence of diabetes worldwide imposes significant economic consequences on the individual’s life. Currently, there are 350 million people worldwide estimated to live with diabetes. Thus continuous monitoring of blood glucose levels is essential in order to manage the ever increasing prevalent population living with diabetes currently. For this reason manufacturers are focusing on developing diagnostic techniques that are highly reliable and monitors individual’s blood glucose levels with greater accuracy with the capability to improve glycemic control and patient wellbeing. By integration of sensing elements, electronics along with a reliable power source in a single unit, noninvasive blood glucose monitors are offering immense opportunity for all the device manufacturers along with patients and various healthcare providers across the world. Accelerated regulatory approvals of blood glucose monitors is one of the another important factor leading to increased revenues of noninvasive blood glucose devices over the forecast period.

Non- Invasive Blood Glucose Monitoring Devices Market: Key Players
Some of the key market players in the non- invasive blood glucose monitoring devices market include:
  • Abbott,
  • Animas Technologies,
  • Bayer Healthcare,
  • Cercacor,
  • Pendragon Medical,
  • OrSense, and Bayer Healthcare.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-2613

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications. 

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
Market Size
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan

Middle East and Africa (GCC, S. Africa, N. Africa)

Buy this report @ https://www.futuremarketinsights.com/checkout/2613

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Pharma and Healthcare Social Media Marketing Market Key Players – Digital Healthcare, Sermo, MomMD, Student Doctors Network, QuantiaMD, Doximity

Pharma and healthcare social media marketing is an area that is extremely relevant to the modern, digital age, where stakeholders in the pharmaceuticals and healthcare industries are reaching out to their potential customers through digital, social media platforms.Social media tools today enable one-to-one interactions among stakeholders and their target customers via content creation, sharing, along with exchange of new ideas and information about products through virtual communities and social networks.

The global market for pharma and healthcare social media marketing services is booming in the information age, as almost all the stakeholders in the pharma and healthcare industries are emerging in the world of social media to market their products, mainly because their potential customers are spending most of their time on social media.

Though social media tools are proving highly effective for the marketing of pharma and healthcare products in the world of customer-centric business, their use is still a matter of debate among end users.

Nevertheless, the overall growth of the global market for pharma and healthcare social media marketing services is expected to witness astonishing growth in the coming years, as a majority of businesses are taking their operations digitally.

Leading players in the market are increasing their focus on crafting creative marketing campaigns to help their customers gain a competitive advantage through more effective interaction and engagement with their target audience consistently.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-403

Social Media Marketing Strategies to Help Strengthen Customer Relationship

Leading players in the pharmaceuticals and healthcare sector have always been experimenting with innovative ways to expand their customer base and gain a competitive advantage, while there are multiple restrictions on the advertising and marketing of pharmaceuticals and medical products.

However, social media platforms have emerged as a useful tool for pharma and healthcare companies to implement effective marketing campaigns that can give amplified results to their efforts of improving engagement, expanding their customer base, and ultimately, dramatically boosting the brand performance in global markets.

Global leaders in the pharmaceuticals and healthcare markets are leveraging the modern social media platforms to establish a new brand identity and creating brand awareness among their existing as well as potential customer bases.

This enables them to create a personal bond with each one of their audience on social media, which further strengthens their customer relationship management operations, and it is expected to further highlight the importance of social media marketing among pharma and healthcare companies in the coming years.

In addition to this, social media marketing is also giving a completely different perspective to pharma and healthcare marketing, as it can also contribute to the end users’ efforts not only in building but also in improving corporate communication and investor relations. It has also helped them improve their customer services even on corporate levels through the implementation of creative social media marketing campaigns.

Involvement of Regulatory Bodies may Restrict the Scope of Social Media Marketing for Pharma and Healthcare Companies

The pharma and healthcare sector is subjected to various rules and regulations regarding the marketing of medical and pharmaceutical products, and this scenario also follows in the planning of social media marketing strategies for these companies.

Governing bodies are modifying their traditional regulatory restrictions on the advertising of drugs and other marketing innovations in the pharma and healthcare industries.

Involvement of regulatory bodies in the global market for pharma and healthcare social media marketing is mainly in the areas of crafting and issuing guidelines in advertising of drugs and biologists through interactive media.

Various policies along with laws and regulations play an instrumental role in deciding the importance and effectiveness of social media in the marketing of pharma and healthcare products, though it restricts the scope of marketing campaigns.

For instance, the United States Food and Drug Administration (FDA) released new guidelines in January 2014, for the pharmaceuticals and healthcare industries defining the regulatory requirements vis-a-vis the marketing submissions for human and animal drugs across social media platforms.

Through its draft, the FDA also clarified various guidelines for content creators and marketers working in the pharmaceutical and healthcare marketing industry while working on the dissemination of branded information about drugs and biologics.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-403

Pharma and Healthcare Social Media Marketing Market: Region-wise Analysis

Based on the geographical factors, the pharma and healthcare social media marketing market is broadly divided into seven regions – North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa.

Though the social media marketing industry has defied all the norms of geographical boundaries, the growth of the  pharma and healthcare social media marketing market is expected to remain significantly high in developed countries – mainly in the United States of America.

With the increasing number of pharma and healthcare companies making a tectonic shift from traditional marketing platforms to social media platforms, the demand for  pharma and healthcare social media marketing services is increasing in North America.

A mounting number of digital marketing agencies are jumping to grab the lucrative opportunities in the North American market for  pharma and healthcare social media marketing.

North America, followed by Europe, is expected to account for a significantly high revenue share in the global pharma and healthcare social media marketing market. However, the digital marketing industry in Asia Pacific is booming with the increasing awareness about social media and growing number of social media users in developing Asian countries – especially in China and India.

Emerging players in the Asia Pacific pharma and healthcare social media marketing market are expected to gain a competitive edge with the use of creative marketing campaigns along with the favourable regulatory environment in the region.

Pharma and Healthcare Social Media Marketing Market: Competitive Landscape

  • Digital Healthcare
  • Sermo
  • MomMD
  • Student Doctors Network
  • QuantiaMD
  • Doximity
  • Healthcare and Medical Software
  • Orthomind
  • WeMedUp
  • Medical Apps
  • DoctorsHangout
  • Nurse Zone
  • All Nurses
  • Medical Doctors
  • Ozmosis

Other pharma and healthcare companies that are highly engaged in social media marketing include Novartis, Johnson & Johnson, Pfizer, Inc., Novo Nordisk, and Bayer AG.

Region-wise Analysis

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Europe (Germany, U.K., France, Italy, Spain, Poland, Russia)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, Thailand, Malaysia, Vietnam, Indonesia)
  • Oceania (Australia, New Zealand)
  • Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa)

Report Highlights

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/403 

Pharma and Healthcare Social Media Marketing Market: Segment Analysis

The pharma and healthcare social media marketing market can be segmented on the basis of the following:

By Social Media Platform

  • Youtube
  • Twitter
  • Instagram
  • Facebook

By End User

  • Healthcare Professionals
  • Hospitals
  • Biotechnology Companies
  • Patients/Consumers

Respiratory Inhaler Devices Market Key Players- AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc.

Global respiratory inhaler device shipments are likely to grow at over 4% in 2021, as the medical device industry makes a gradual recovery. Innovation in smart inhaler technologies is likely to be a key focus area, but manual inhalers will still account for 90% of total demand. This stark contrast reflects the status-quo in the global medical device industry, where realization of new investment and bottom-lines are concurrent.

[250 Pages Report] The rising prevalence of respiratory disorders has necessitated innovation in manufacture of respiratory inhalers. The demand for better precision in drug delivery is enabling broader adoption of Respiratory Inhaler Devices, especially among patients of asthma and chronic obstructive pulmonary diseases (COPD). Steady growth is expected to continue as favorable reimbursement policies by governments create a conducive environment around the world.

Global demand for respiratory inhaler devices continues to be driven by rising prevalence of COPD and asthma. According to the World Health Organization (WHO), nearly 251 million cases of chronic obstructive pulmonary disease (COPD) were reported worldwide in 2016 and nearly 339 million people were estimated to have asthma in the same year. Coupled with this, surging healthcare spending has been creating lucrative prospects for growth of the market.

Market players also are focusing on novel inhalation technologies to ascertain drug delivery to lungs. Spurred by these factors, the global market for respiratory inhaler devices is expected to report surging sales.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-493

Smart Inhaler Technology Touted as a Major Breakthrough

Smart inhalers have been touted as a disruptive technology, and it remains a key focus area for manufacturers. Smart inhalers can signal patients if their overusing any medication, warning them against poor management of the condition. The technology is touted as a major breakthrough in the healthcare sector and one that is expected to enable growth in the respiratory inhaler devices market in the coming years.

Several studies already are underway gauging the potential of these development. For instance, My AirCoach, which is an EU-funded multi-institutional research project, aims at assessing how novel mobile health technologies, including smart inhalers, can help offering improved asthma control.

With myriad of developments underway, respiratory inhaler device shipments are likely to gain traction through 2030. FMI’s report offers a comprehensive analysis on how growth will unfold. Some of the key takeaways from the report are:

  • Dry powder inhalers remain the most lucrative category
  • Manually operated inhaler devices will remain preferred choice among available technologies
  • Respiratory inhaler devices sales surging to offer improved asthma control and management
  • US to remain a highly lucrative market for respiratory inhaler devices, however, growth in East Asia is expected to accelerate at a higher pace

“Some of the leading players are working on technologies that would enable monitoring and correction of inhalation techniques in the near future. They are developing smart inhalers that will use the Bluetooth technology to monitor inhaler use in patients. While several developments are underway, industry experts are cautiously examining the potential of smart inhalers to ensure all potential concerns pertaining to the novel technologies are ironed out. However once launched, smart technology can help the market gain momentum at accelerated pace in the near future,” said a lead analyst at FMI.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-493

Some of the leading companies are focusing on innovations and product launches to gain competitive advantage. There also are companies trying to capitalize on opportunities across high potential markets. For instance, Zydus Cadila has announced launching India’s first pressurized Metered Dose Inhaler (pMDI) – Forglyn pMDI with a combination of Long Acting Beta Agonist (LABA) and Long Acting Muscarinic Antagonist (LAMA) for COPD patients in October 2020.

In 2019, Lupin announced launching “ADHERO,” which is a connected smart device for metered dose inhalers and promises to ensure improved adherence to inhalation therapy for COPD treatment.

In the latest report by Future Market Insights, we offer an unbiased analysis of the global respiratory inhaler devices market, providing historical data for the period of 2015-2019 and forecast statistics for the period of 2020-2030. In order to understand the global market potential, its growth and scopes, the market is segmented on the basis of product type (dry powder inhaler, metered dose inhaler, and nebulizer), technology (manually operated inhaler devices and digitally operated inhaler devices), disease indication (asthma, COPD, pulmonary arterial hypertension, other respiratory diseases), across six major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, MEA).

Key Segments

Product

  • Dry Powder Inhalers
  •  Metered Dose Inhalers
  • Nebulizers
    • Compressed Air Nebulizers
    • Ultrasonic Nebulizers
    • Mesh Nebulizers

Technology

  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices

Disease Indication

  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Others

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/493

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Middle East and Africa (MEA)
  • Oceania

U.S. Compounding Pharmacies Market is expected to grow at over 5.1% CAGR between 2022 and 2028

[81 Pages Report] According to a recent research by Future Market Insights (FMI), the global compounding pharmacies market is estimated to have accounted around US$ 8 Bn in terms of value during 2022. The report on the U.S. compounding pharmacies market also projects that the market will grow at a CAGR of approximately 5% during the period 2022-2028.

The U.S. compounding pharmacies market revenue is expected to increase at a robust growth rate over the next few years despite the reporting of several adverse events and drug mismanagement-related deaths. The U.S. compounding pharmacies market is expected to gain popularity in several regions of the U.S. due to upcoming products and therapeutic areas that are yet to be tapped by branded manufacturers.

Focus on factors, such as the availability of drugs in innovative medium/forms and the administration of varying dosages for various indications, is expected to drive the adoption of newer dosage forms of compounded medications.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-978

Market Remains Influenced by Availability of Compounded Pain Management Drugs

The growing popularity of pain management therapies is fuelling the growth of U.S. compounding pharmacies market. Compounded pain management drugs are not FDA-approved, however, they come under the State Pharmacies Board supervision in the U.S.

For example, medical guidelines such as the Chronic Pain Guidelines stated by the Medical Treatment Utilization Schedule (MTUS) do not support the use of compounds such as Gabapentin and Baclofen for pain management. However, compounding pharmacies use these compounds as well as several others in varying strengths to attract customers and increase their revenue.

Moreover, an increase in the shortage of prescription medicine is expected to upsurge the demand for compounding pharmacies. According to the U.S. FDA, only 154 drugs were in short supply or not available in 2007, as compared to 456 in 2012.

Currently, the number of drugs in short supply is around 300. Medicinal drought is prominent in the U.S. as compared to other countries, which is also fuelling the revenue growth of the U.S. compounding pharmacies market.

On the other hand, increasing regulatory pressures are expected to hamper the growth of the U.S. compounding pharmacies market. Compounding pharmacies are engaged in trans-boundary drug compounding, and the manufacturing of bulk drugs & ingredients need to be registered with the FDA, undergo mandatory inspections, and abide by GMP guidelines.

For instance, the FDA has stated that around 70% of registered firms have been inspected, of which 28 firms have been issued FDA Form 483s (non-adherence to cGMP regulations and unsafe compounding practices), and five warning letters, which implies a very high rate of action.

Compounding pharmacies registering with the FDA could serve to increase credibility. However, inspections and compliance with good manufacturing practices is compulsory. Regulatory pressures on compounding pharmacies are expected to force the smaller ones to close their business primarily due to unsafe compounding practices, which are likely to directly impact patient safety.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-978

Hormone Replacement Therapeutic Area to Hold over 38% Revenue Share in Market

By product type, oral medication is the expected to dominate the U.S. compounding pharmacies market in term of revenue, which is then followed by topical medication. The injectable segment by product type of the U.S. compounding pharmacies market is projected to grow at a significant rate as compared to other segments.

The hormone replacement therapy segment is the leading segment in terms of revenue among all the therapeutic area segments of the U.S. compounding pharmacies market, and is estimated to gain a 38.4% revenue share in 2022.

Among the pharmacy type segments, the 503A pharmacy segment is expected to gain a major revenue share as compared to the 503B pharmacy segment over the forecast period. By application, the adults segment is estimated to dominate the U.S. compounding pharmacies market, followed by the paediatrics segment.

The veterinary segment is expected to grow at a faster pace as compared to the other application segments of the U.S. compounding pharmacies market.

The U.S. compounding pharmacies market report tracks some of the key companies operating in the market, which include Avella Specialty Pharmacy, Central Admixture Pharmacy Services, Inc., Fagron N.V., Wedgewood Pharma, PharMEDium Services LLC, Doughertys Pharmacy, Institutional Pharmacy Solutions, Lorraine’s Pharmacy, Village Compounding Pharmacy, Triangle Compounding Pharmacy, Olympia Pharmacy, Hoye’s Pharmacy, Vertisis Custom Pharmacy, Smith Caldwell Drug Store, AIS HealthCare, Soleo Health, Millers Pharmacy, Centene Corporation, Infinity Care Solutions, Triumph Pharmacy, and Sixth Avenue Medical Pharmacy.

U.S. Compounding Pharmacies Market By Category

By Product :

  • Oral Medication
    • Solid Medication
      • Capsules
      • Tablets
      • Mixtures
      • Lollipops
      • Lozenges
    • Liquid Medication
      • Syrup
      • Solution/li>
      • Emulsion
      • Suspension
    • Topical Medication
      • Gels
      • Ointments
      • Creams
      • Lotions
  • Injectable
  • Mouthwashes
  • Nasal
  • Ocular
  • Otic
  • Suppositories and Enemas

By Pharmacy Type :

  • 503A Pharmacy
  • 503B Pharmacy

By Application :

  • Adults
  • Pediatrics
  • Geriatrics
  • Veterinary

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-978

By Therapeutic Area :

  • Hormone Replacement Therapy
  • Pain Management
  • Dermatology
  • Oncology
  • Hematology
  • Dental
  • Others

General Anesthesia Drugs Market is expected to grow at a CAGR of ~3% during the forecast period of 2022-2029

A new study of Future Market Insights (FMI) indicates that the global general anesthesia drugs market is poised for steady growth in the years ahead. Today, the general anesthesia drugs market remains driven by increased proportion of elderly patients and rising volume of surgical procedures; FMI analyst forecasts the market to witness 3.5% CAGR during the period, 2019-2029.

According to the FMI analyst, worldwide sales of general anesthesia drugs will increase ~3% year-over-year to total ~US$ 4.3 billion in 2019, up from US$ 4.17 billion in 2018. The analyst identifies growth opportunities in the development of new drugs that can overcome shortcomings such as adverse effects, procedural complications and allergic reactions.

As the development of ultra-short acting hypnotic or sedative agent without adverse effects remains an unfulfilled dream, a search for newer drugs and clinical trials of formerly withdrawn drugs to remove the undesirable effects while maintaining their beneficial effects have been underway. Collaborating with research institutes to understand the challenges in designing and developing effective drugs will continue to be a key focus area of manufacturers as well.

Propofol IV Drugs Continue to Witness Significant Adoption

Relatively high adoption of propofol intravenous drugs in large number of surgeries performed globally continues to influence growth strategies, which accounted for ~25% revenue share in 2018.

“While many anesthesiologists prefer the use of propofol for its lipophilic nature and rapid onset of action on the body, water soluble formulations of propofol are being developed to address the disadvantages associated with lipid formulations such as hyperlipidemia, pain on injection, and bacterial growth,” said the FMI analyst.

The FMI analyst predicts the sales of inhalation anesthetics such as sevoflurane to be valued at ~US$ 830 million in 2019, while the sales of desflurane is likely to increase 2.5% in that year. On the one hand, midazolam and remifentanil continue to represent the lowest revenue shares in the market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-388

Adoption in Ambulatory Surgical Centers to Ramp up in 2019

General anesthesia drugs worth US$ 1.8 billion were sold in hospitals in 2018, driven by rising number of hospitals along with the emergence of favorable reimbursement policies across the globe.

“A notable increase in ambulatory surgeries and rising utilization of general anesthesia drugs for outpatient procedures have been significantly contributing to the market growth,” said the FMI analyst.

In 2018, general anesthesia drugs sold in ambulatory surgical centers totaled a revenue worth ~US$ 1.4 billion, and is estimated to record 3% high in 2019.

North America, Europe, and East Asia Markets in the Vanguard

North America continues to acquire the leading position in general anesthesia drugs market, accounting for a 30% revenue share in 2018 total, followed by Europe and East Asia.

The FMI analyst anticipates a rising number of complexity of medical interventions requiring induction and maintenance of general anesthesia drugs in several nations in Europe, driven further by an ongoing aging of population. Sales in the region are likely to exhibit a CAGR of 3% during the forecast period.

East Asia (24% share) will continue to greater opportunities for the market players, in the view of rising approvals of drugs along with favorable government initiatives for the development of healthcare infrastructure.

“Although the demand for general anesthesia drugs directly correlates with the advancements in complex surgeries, manufacturers will need to direct their investments towards R&D for safer drugs, considering the uncertain study results relative to the impact of general anesthesia drugs on developing as well as aging brain,” said the FMI analyst.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-388

GENERAL ANESTHESIA DRUGS MARKET TAXONOMY

The global general anesthesia drugs market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

By Drug Class

  • Propofol
  • Sevoflurane
  • Dexmedetomidine
  • Desflurane
  • Remifentanil
  • Midazolam
  • Others
  • (Others – Sufentanil, Fentanyl, Ketamine, Isoflurane, Thiopental etc.)

By Route of Administration

  • Intravenous Anesthesia
  • Inhaled Anesthesia

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/388

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA

Automated Breast Ultrasound System Market is slated to grow at approximately 10% CAGR during the forecast period 2022 – 2031

Rising prevalence of breast cancer across the globe and increasing government initiatives undertaken to encourage breast cancer awareness have significantly fuelled the demand for automated breast ultrasound system, according to ESOMAR-certified Future Market Insights’ (FMI) latest research report. As per the study, the global automated breast ultrasound system market is slated to grow at approximately 10% CAGR over the forthcoming decade.

Key manufacturers are actively focusing on developing faster, accurate and minimal invasive ultrasound breast imaging system. According to report published in National Library of Medicine, integration of mammography with automated breast ultrasound system increased the sensitivity of the system to 99.1%.

The combination drastically improves cancer detection rate among dense breasted women and reduces the interpretation time. Prominent manufacturer GE Healthcare launched a new automated breast ultrasound system named “Invenia” in U.S in October 2018. The main function of the system is to identify the presence of mammographically occult cancer especially in women with dense tissues.

With various other developments on cards, the automated breast ultrasound system market is expected to showcase impressive growth between 2021 and 2031.

To remain ‘ahead’ of your competitors, request for a sample

Key Takeaways from FMI’s Automated Breast Ultrasound Systems Market Study

Increasing government investment to promote breast cancer awareness among women will bolster demand across the U.S.

The U.K is expected to experience noteworthy growth as governments and private organizations aim at curbing high mortality rate due to breast cancer.

Presence of modern healthcare infrastructure will increase automated breast ultrasound system adoption across Germany

Saudi Arabia will offer lucrative opportunities owing to rapid urbanization and emergence of advance diagnostics centers.

India is expected to exhibit increasing demand owing to increase in per capita income and to growing incidence of breast cancer among women.

Hospitals are expected to lead the market driven by faster accessibility modern tool and availability of skilled professionals.

“Visibly rising consumer inclination towards radiation free imaging and diagnostics systems is likely to intensify sales of automated breast ultrasound system among diagnostics laboratories,” says the FMI analyst.

Competitive Landscape

GE Electric Co., Siemens A.G., Hitachi Ltd., SonoCiné Inc., Koninklijke are some prominent players operating in the automated breast ultrasound system market. They are focusing on improving the accuracy of automated breast ultrasound system for faster assessment of cancer screening in addition to getting government approval for their products.

For instance, Hitachi being the global leader in smart life & eco-friendly systems launched its latest automated breast ultrasound system “SOFIA” capable of scanning and acquiring image of the complete breast.

Koninklijke launched Philips EPIQ and Affiniti ultrasound systems as a part of its automated breast ultrasound system product range. Philips EPIQ is laced with an integrated eL18-4 transducer and employs anatomical intelligence for accurate imaging of the breast with high tissue density.

Key Points Covered

Market estimates and forecast 2015-2031

Key drivers and restraints impacting market growth

Segment-wise, Country-wise, and Region-wise Analysis

Competition Mapping and Benchmarking

Brand share and Market Share Analysis

Key Product Innovations and Regulatory Climate

COVID-19 Impact on Automated Breast Ultrasound System Market and How to Navigate

Recommendation on Key Winning Strategies

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-606

Key Segments Covered

 

By End User

Hospitals

Diagnostic Imaging Laboratories

Region

North America

U.S.

Canada

Latin America

Brazil

Mexico

Argentina

Rest of Latin America

Western Europe

EU-5

BENELUX (Belgium, Netherlands, Luxembourg)

NORDIC (Denmark, Finland, Iceland, Norway, Sweden)

Rest of Europe

Eastern Europe

Poland

Russia

Rest of Eastern Europe

Japan APEJ (Asia Pacific excluding Japan)

China

India

ASEAN Countries

Australia & New Zealand

Rest of APEJ

MEA

GCC Countries

South Africa

Israel

Turkey

Iran

Rest of Middle East & Africa

For in-depth competitive analysis Buy Now – https://www.futuremarketinsights.com/checkout/606

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Automated CPR Devices Market is slated to grow at approximately 13% CAGR throughout the forecast period from 2022 to 2031

The demand for automated CPR devices has been increasing significantly with rising prevalence of sudden cardiac arrest across the globe, according to ESOMAR-certified Future Market Insights’ (FMI) latest research report. As per the study, the global automated CPR devices market is slated to grow at approximately 13% CAGR throughout the forecast period from 2021 to 2031.

Major progress has been witnessed with 3D automatic CPR devices, especially when normal CPR device coupled with torso restraints providing vertical compression and high quality resuscitation.

Automated CPR devices experienced a surge in demand during the Covid-19 pandemic. COVID-19 infected heart patients were more susceptible to cardiac arrest in comparison with non infected patients. With rapid mutation of virus, the patients were facing higher risk of cardiac arrest.

The market is anticipated to grow significantly over the forthcoming decade, as majority of coronary and intensive care units are inclining towards automated CPR devices for its high effectiveness.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-720

automated cpr devices market key region and compressor type analysis, 2021-2031

Key Takeaways from FMI’s Automated CPR Devices Market Study

  • Presence of modern healthcare infrastructure and high per capita income will bolster demand across the U.S.
  • The U.K is expected to offer growth opportunities as governments and private organizations are working towards spreading awareness regarding dangers of cardiovascular diseases.
  • Rising prevalence of obesity and high blood pressure which are precursor to cardiac arrest will increase automated CPR devices adoption across France.
  • China will offer lucrative opportunities owing to increasing alcohol and tobacco consumption and developing healthcare infrastructure.
  • India is expected to exhibit impressive market growth owing to increase in geriatric population and growing incidence of sudden cardiac arrest in the country.

 “Rising consumer awareness regarding benefits of CPR devices and increasing adoption in EMT services will amplify sales of automated CPR devices during the forecast period,” says the FMI analyst.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-720

Competitive Landscape

Automated CPR market is highly consolidated owing to presence of regional and global market players. Key market players in automated CPR devices market are focusing towards employing inorganic market strategies to expand their global foothold.

Inorganic strategies include strategic merger and acquisition and forming an alliance with regional distributors to strengthen their supply chain channels.

They are also emphasizing towards faster product approvals, product development and patenting. New market entrants are focusing on new product launches to establish their market presence.

For instance, Michigan Instruments launched hand-free automatic CPR device which is light weight, portable and helps in smooth transition from manual CPR to automated compressions.

ZOLL Medical Corporation introduced a new automated CPR devices system “Autopulse” which assists EMS personnel in providing high quality chest compressions in cramped spaces and steep down stairwells.

Prominent players operating in the automated CPR devices market are SunLife Science Inc., ZOLL Medical Corporation, Michigan Instruments, Physio Control Inc., Brunswick Biomedical Technologies, Zhuhai Kindway Medical Science & Technology Co. Ltd, CPR Medical Devices Inc., and Medtronic Inc.

 

In its latest report, FMI offers an unbiased analysis of the global automated CPR devices market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of power source (pneumatically driven CPR devices, battery driven CPR devices, and mechanically actuated and battery driven CPR device), device type (piston devices, load distribution devices, and 3D compression devices) and end user for (Ems, hospitals, ambulances, coronary & intensive care units, cardiac catheterization labs, air med-evac units, and EMT rescue units) across North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa.

Key Segments Covered

By Power Source

  • Pneumatically Driven CPR Devices
  • Battery Driven CPR Devices
  • Mechanically Actuated And Battery Driven CPR Device

By Device Type

  • Piston Devices
  • Load Distribution Devices
  • 3D Compression Devices

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-720

By End User

  • EMS
  • Hospitals
  • Ambulances
  • Coronary & Intensive Care Units
  • Cardiac Catheterization Labs
  • Air Med-Evac Units
  • EMT Rescue Units
  • Others

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Chlorinated Polyethylene Resins and Elastomers (CEP) Market Estimated to Record Highest CAGR by 2025

Chlorinated polyethylene (CPE) resins and elastomersare thermoplastic polymers exhibiting enhanced physical and chemical properties. These are used as thermoplastic elastomer, modifier for various resins such as Polyvinyl chloride (PVC), Acrylonitrile butadiene styrene (ABS) andPolyethyelene(PE). Chlorinated polyethylene resins offer resistance against chemical, fire, heat, oil, weather, abrasion. Other properties of CPE include excellent mechanical and physical properties, high filler acceptance, tensile strength and low temperature performance. The applications of chlorinated polyethylene resins and elastomers include geomembranes, as impact modifier andflexible sheeting for automotive, roofing membranes, molded shapes, extruded profiles and cable jacketing and as a base polymer.

Growing demand for chlorinated polyethylene resins and elastomers in impact modification application is expected to drive the market growth. Impact modification is the largest application of CPE in terms of consumption. It is widely used for impact modification of PVC for fence, deck, window profiles, pipes and vinyl siding.

Get a Free Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-318

CPEs are added into formulations of PVC, PE and PP plastic products to improve impact resistance, low temperature performance, welding strength, and weatherability. In addition, growing demand from flexible sheetingelectrical wires and cables, roofing applications and rubber products for seals and shoe soles.

Flexible sheeting industry is experiencing high growth in Asia Pacific region due to growing construction and electrical industries. These two industries are driven by changing lifestyle and rising disposable income.Further, rising demand from automobile hoses and industrial hoses is expected to fuel the chlorinated polyethylene resins and elastomers market growth. Owing to properties such as ozone resistance, chemical resistance, oil resistance and temperature resistance, CPE has become ideal choice for applications such as oil tubes, power steering tubes, delivery tubes of cooling fluids. It can be also used for vent and vacuum tubes in automotive. Automobile industry is driven by global demand for various types of automotives for variety of applications. Industrial hoses are used for chemical delivery and oil delivery in difference machineries of manufacturing plants.

Request Report Methodology: https://www.futuremarketinsights.com/askus/rep-gb-318

However, rising crude oil prices and hence volatility in raw materials prices are expected to hamper the market growth for chlorinated polyethylene resins and elastomers. Polyethylene is manufactured from crude oil derivatives and is subjected to availability and price variations. In addition, high cost of processing to develop the application specific elastomer or resin is expected to hamper the market growth.

Development of new applications in healthcare and pharmaceutical are expected to provide opportunities for the players in the market. Due to non-hazardous nature of chlorinated polyethylene resins and elastomers, it can be used for manufacturing plants of pharmaceuticals and healthcare industry.

Asia Pacific was largest market for chlorinated polyethylene resins and elastomers in terms of consumption. China accounts for largest share in the global market in terms of production and consumption. Most of CPE in China is used for impact modifier and hoses application. Asia Pacific was followed by North America where the U.S. was the largest consumer. Demand from Europe and Rest of the World is expected to grow at moderate pace.

Global chlorinated polyethylene resins and elastomers market is highly concentrated with few players dominating the market. Most of the players have their manufacturing plant in China and threat from Chinese players is moderate due to high cost of processing.

Key players in Chlorinated polyethylene resins and elastomers market include the Dow Chemical Company, Sundow Polymers Co. Ltd., Lianda Corporation, Du Pont, Novista – Sanyi Chemical, WeifangPolygrandChemical Co.Ltd., Shandong SanyiIndustrial Co. Ltd., Cevo Industry Company Ltd. among others.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-318

 

This research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically-supported and industry-validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as market segments, regions, product types and distribution channels.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size & Forecast 2015 -2025
  • Supply & Demand Value Chain
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain
  • Market Drivers and Restraints

Regional analysis includes

  • North America
    • US & Canada
  • Latin America
    • Brazil, Argentina & Others
  • Western Europe
    • EU5
    • Nordics
    • Benelux
  • Eastern Europe
  • Asia Pacific
    • Australia and New Zealand (ANZ)
    • Greater China
    • India
    • ASEAN
    • Rest of Asia Pacific
  • Japan
  • Middle East and Africa
    • GCC Countries
    • Other Middle East
    • North Africa
    • South Africa
    • Other Africa
Chlorinated Polyethylene Resins Elastomers Market

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth.

Contact Us:                                                      

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com